Pre-clinical evidence for the use of XPO-1 inhibitors in myeloma
R. Rahme, Paris, France
Selinexor: the latest clinical data
M. Mohty; Paris, France
Amrita Krishnan, MD
City of Hope National Cancer Center, California, US
Dr Amrita Krishnan is a leading expert and Executive Medical Director in the Department of Hematology at the City of Hope National Cancer Center in Orange County, California, US. Dr Krishnan directs the Judy and Bernard Briskin Center for Multiple Myeloma Research and served as a steering committee member on the Multiple Myeloma Research Foundation. She is also a board member of the International Myeloma Society and co-chair for several myeloma transplant trials in the US.
Aurore Perrot, MD PhD
University Hospital of Toulouse, France
Dr Aurore Perrot is a Professor in Hematology at the Cancer Research Center of Toulouse in France. Dr Perrot is a member of the Intergroupe Francophone du Myélome (IFM) research group and is involved in a number of trials investigating anti-CD38 monoclonal antibodies and genomics in multiple myeloma. She has also authored several myeloma publications which focus on the latest developments in multiple myeloma.
This site place cookies on your machine for reasons including keeping track of your preferences, collecting aggregated statistics to analyze how our site is used, and to show you ads tailored to your interests. ACCEPT
Privacy, Cookies Policy, General Terms and Conditions of Use
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.